Clofoctol: Difference between revisions
m (Bot: Automated text replacement (-{{SIB}} + & -{{EH}} + & -{{EJ}} + & -{{Editor Help}} + & -{{Editor Join}} +)) |
Rabin Bista (talk | contribs) No edit summary |
||
Line 1: | Line 1: | ||
{{ | {{Drugbox | ||
| IUPAC_name | | Watchedfields = changed | ||
| image | | verifiedrevid = 443553734 | ||
| IUPAC_name = 2-[(2,4-dichlorophenyl)methyl]-<br>4-(2,4,4-trimethylpentan-2-yl)phenol | |||
| | | image = Clofoctol Wiki Str.png | ||
| | |||
| alt = Structural formula of clofoctol | |||
| width = 250 | |||
<!--Clinical data--> | |||
| tradename = | |||
| | | Drugs.com = {{drugs.com|international|clofoctol}} | ||
| | | pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X --> | ||
| | | pregnancy_US = <!-- A / B / C / D / X --> | ||
| | | pregnancy_category = | ||
| pregnancy_AU | | legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 --> | ||
| pregnancy_US | | legal_CA = <!-- / Schedule I, II, III, IV, V, VI, VII, VIII --> | ||
| pregnancy_category= | | legal_UK = <!-- GSL / P / POM / CD / Class A, B, C --> | ||
| legal_AU | | legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V --> | ||
| legal_CA | | legal_status = | ||
| legal_UK | | routes_of_administration = Rectal ([[suppository]])<ref name=Gramplus/> | ||
| legal_US | |||
| legal_status | <!--Pharmacokinetic data--> | ||
| routes_of_administration = Rectal ([[suppository]])<ref name=Gramplus/><ref name= | | bioavailability = 98%<ref name=Gramplus/> | ||
| protein_bound = | |||
| metabolism = [[Hepatic]] [[glucuronidation]]<ref name=Gramplus/> | |||
| elimination_half-life = | |||
| excretion = Biliary<ref name=Gramplus/> | |||
<!--Identifiers--> | |||
| CAS_number_Ref = {{cascite|correct|??}} | |||
| CAS_number = 37693-01-9 | |||
| ATC_prefix = J01 | |||
| ATC_suffix = XX03 | |||
| PubChem = 2799 | |||
| DrugBank_Ref = {{drugbankcite|correct|drugbank}} | |||
| DrugBank = | |||
| ChEMBL = 1476605 | |||
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}} | |||
| ChemSpiderID = 2697 | |||
| UNII_Ref = {{fdacite|correct|FDA}} | |||
| UNII = 704083NI0R | |||
| KEGG_Ref = {{keggcite|correct|kegg}} | |||
| KEGG = D07244 | |||
<!--Chemical data--> | |||
| C=21 | H=26 | Cl=2 | O=1 | |||
| molecular_weight = 365.336 g/mol | |||
| smiles = Clc1cc(Cl)ccc1Cc2cc(ccc2O)C(C)(C)CC(C)(C)C | |||
| InChI = 1/C21H26Cl2O/c1-20(2,3)13-21(4,5)16-7-9-19(24)15(11-16)10-14-6-8-17(22)12-18(14)23/h6-9,11-12,24H,10,13H2,1-5H3 | |||
| InChIKey = HQVZOORKDNCGCK-UHFFFAOYAB | |||
| StdInChI_Ref = {{stdinchicite|correct|chemspider}} | |||
| StdInChI = 1S/C21H26Cl2O/c1-20(2,3)13-21(4,5)16-7-9-19(24)15(11-16)10-14-6-8-17(22)12-18(14)23/h6-9,11-12,24H,10,13H2,1-5H3 | |||
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}} | |||
| StdInChIKey = HQVZOORKDNCGCK-UHFFFAOYSA-N | |||
}} | }} | ||
__NOTOC__ | |||
{{SI}} | {{SI}} | ||
{{CMG}} | |||
== Overview == | |||
'''Clofoctol''' is a [[bacteriostatic]] [[antibiotic]]. It is used in the treatment of [[respiratory tract]] and ear, nose and throat infections caused by [[Gram-positive]] [[bacteria]].<ref name=Gramplus>{{cite web | url = http://www.torrinomedica.it/studio/schedefarmaci/GRAMPLUS.htm | title = Gramplus | date = July 25, 2007 | accessdate = 2007-08-10 | publisher = Studio Medico Torrino | language = Italian}}</ref> | |||
It is marketed in [[France]] under the trade name '''Octoplus''' and in [[Italy]] as '''Gramplus'''. | |||
It is only functional against [[Gram-positive bacteria]].<ref name="pmid6782374">{{cite journal |author=Combe J, Simonnet F, Yablonsky F, Simonnet G |title=[Clofoctol binding by the bacteria (author's transl)] |language=French |journal=J Pharmacol |volume=11 |issue=4 |pages=411–25 |year=1980 |pmid=6782374 |doi=}}</ref> | |||
It | It penetrates into human lung tissue.<ref name="pmid3391105">{{cite journal |author=Danesi R, Gasperini M, Senesi S, Freer G, Angeletti CA, Del Tacca M |title=A pharmacokinetic study of clofoctol in human plasma and lung tissue by using a microbiological assay |journal=Drugs Exp Clin Res |volume=14 |issue=1 |pages=39–43 |year=1988 |pmid=3391105 |doi= |url=}}</ref> | ||
==References== | ==References== | ||
{{Reflist}} | {{Reflist|2}} | ||
{{Antibiotic-stub}} | |||
{{Other antibacterials}} | {{Other antibacterials}} | ||
[[Category:drug]] | |||
[[Category:Antibiotics]] | [[Category:Antibiotics]] | ||
[[Category:Phenols]] | |||
[[Category:Organochlorides]] | |||
Latest revision as of 15:36, 14 April 2015
Clinical data | |
---|---|
AHFS/Drugs.com | International Drug Names |
Routes of administration | Rectal (suppository)[1] |
ATC code | |
Pharmacokinetic data | |
Bioavailability | 98%[1] |
Metabolism | Hepatic glucuronidation[1] |
Excretion | Biliary[1] |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
E number | {{#property:P628}} |
ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
Chemical and physical data | |
Formula | C21H26Cl2O |
Molar mass | 365.336 g/mol |
3D model (JSmol) | |
| |
| |
(verify) |
WikiDoc Resources for Clofoctol |
Articles |
---|
Most recent articles on Clofoctol |
Media |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Clofoctol at Clinical Trials.gov Clinical Trials on Clofoctol at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Clofoctol
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Clofoctol Discussion groups on Clofoctol Directions to Hospitals Treating Clofoctol Risk calculators and risk factors for Clofoctol
|
Healthcare Provider Resources |
Causes & Risk Factors for Clofoctol |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Clofoctol is a bacteriostatic antibiotic. It is used in the treatment of respiratory tract and ear, nose and throat infections caused by Gram-positive bacteria.[1] It is marketed in France under the trade name Octoplus and in Italy as Gramplus.
It is only functional against Gram-positive bacteria.[2]
It penetrates into human lung tissue.[3]
References
- ↑ 1.0 1.1 1.2 1.3 1.4 "Gramplus" (in Italian). Studio Medico Torrino. July 25, 2007. Retrieved 2007-08-10.
- ↑ Combe J, Simonnet F, Yablonsky F, Simonnet G (1980). "[Clofoctol binding by the bacteria (author's transl)]". J Pharmacol (in French). 11 (4): 411–25. PMID 6782374.
- ↑ Danesi R, Gasperini M, Senesi S, Freer G, Angeletti CA, Del Tacca M (1988). "A pharmacokinetic study of clofoctol in human plasma and lung tissue by using a microbiological assay". Drugs Exp Clin Res. 14 (1): 39–43. PMID 3391105.
- Pages with script errors
- CS1 maint: Unrecognized language
- CS1 maint: Multiple names: authors list
- Template:drugs.com link with non-standard subpage
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Chemical articles with unknown parameter in Infobox drug
- Chemical pages without DrugBank identifier
- Drugs with no legal status
- Drugboxes which contain changes to watched fields
- Drug
- Antibiotics
- Phenols
- Organochlorides